These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 34729526

  • 1. Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey.
    Nativi-Nicolau J, Siu A, Dispenzieri A, Maurer MS, Rapezzi C, Kristen AV, Garcia-Pavia P, LoRusso S, Waddington-Cruz M, Lairez O, Witteles R, Chapman D, Amass L, Grogan M, THAOS Investigators.
    JACC CardioOncol; 2021 Oct; 3(4):537-546. PubMed ID: 34729526
    [Abstract] [Full Text] [Related]

  • 2. Characteristics of patients with autonomic dysfunction in the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Barroso FA, Coelho T, Dispenzieri A, Conceição I, Waddington-Cruz M, Wixner J, Maurer MS, Rapezzi C, Planté-Bordeneuve V, Kristen AV, González-Duarte A, Chapman D, Stewart M, Amass L, THAOS investigators.
    Amyloid; 2022 Sep; 29(3):175-183. PubMed ID: 35451899
    [Abstract] [Full Text] [Related]

  • 3. Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Campbell CM, LoRusso S, Dispenzieri A, Kristen AV, Maurer MS, Rapezzi C, Lairez O, Drachman B, Garcia-Pavia P, Grogan M, Chapman D, Amass L, THAOS investigators.
    Cardiol Ther; 2022 Sep; 11(3):393-405. PubMed ID: 35583798
    [Abstract] [Full Text] [Related]

  • 4. Age- and Sex-Related Differences in Patients With Wild-Type Transthyretin Amyloidosis: Insights From THAOS.
    Mora-Ayestaran N, Dispenzieri A, Kristen AV, Maurer MS, Diemberger I, Drachman BM, Grogan M, Gupta P, Glass O, Amass L, Garcia-Pavia P, THAOS Investigators.
    JACC Adv; 2024 Aug; 3(8):101086. PubMed ID: 39105117
    [Abstract] [Full Text] [Related]

  • 5. Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS.
    Caponetti AG, Rapezzi C, Gagliardi C, Milandri A, Dispenzieri A, Kristen AV, Wixner J, Maurer MS, Garcia-Pavia P, Tournev I, Planté-Bordeneuve V, Chapman D, Amass L, THAOS Investigators.
    JACC Heart Fail; 2021 Oct; 9(10):736-746. PubMed ID: 34391735
    [Abstract] [Full Text] [Related]

  • 6. Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Gentile L, Diemberger I, Plante-Bordeneuve V, Mazzeo A, Dori A, Luigetti M, Di Paolantonio A, Dispenzieri A, Grogan M, Waddington Cruz M, Adams D, Inamo J, Kristen AV, Lino Cirami C, Chapman D, Gupta P, Glass O, Amass L.
    PLoS One; 2024 Oct; 19(1):e0292435. PubMed ID: 38241252
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.
    Rapezzi C, Elliott P, Damy T, Nativi-Nicolau J, Berk JL, Velazquez EJ, Boman K, Gundapaneni B, Patterson TA, Schwartz JH, Sultan MB, Maurer MS.
    JACC Heart Fail; 2021 Feb; 9(2):115-123. PubMed ID: 33309574
    [Abstract] [Full Text] [Related]

  • 8. A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Gentile L, Coelho T, Dispenzieri A, Conceição I, Waddington-Cruz M, Kristen A, Wixner J, Diemberger I, Gonzalez-Moreno J, Cariou E, Maurer MS, Planté-Bordeneuve V, Garcia-Pavia P, Tournev I, Gonzalez-Costello J, Duarte AG, Grogan M, Mazzeo A, Chapman D, Gupta P, Glass O, Amass L, THAOS investigators.
    Orphanet J Rare Dis; 2023 Nov 10; 18(1):350. PubMed ID: 37946256
    [Abstract] [Full Text] [Related]

  • 9. Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update.
    Dispenzieri A, Coelho T, Conceição I, Waddington-Cruz M, Wixner J, Kristen AV, Rapezzi C, Planté-Bordeneuve V, Gonzalez-Moreno J, Maurer MS, Grogan M, Chapman D, Amass L, THAOS investigators.
    Orphanet J Rare Dis; 2022 Jun 18; 17(1):236. PubMed ID: 35717381
    [Abstract] [Full Text] [Related]

  • 10. A natural history analysis of asymptomatic TTR gene carriers as they develop symptomatic transthyretin amyloidosis in the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Coelho T, Conceição I, Waddington-Cruz M, Keohane D, Sultan MB, Chapman D, Amass L, THAOS investigators.
    Amyloid; 2022 Dec 18; 29(4):228-236. PubMed ID: 35730447
    [Abstract] [Full Text] [Related]

  • 11. Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
    Razvi Y, Ioannou A, Patel RK, Chacko L, Karia N, Riefolo M, Porcari A, Rauf MU, Starr N, Ganesananthan S, Blakeney I, Kaza N, Filisetti S, Bolhuis RE, Rowczenio D, Gilbertson J, Hutt D, Mahmood S, Lachmann HJ, Wechalekar AD, Kotecha T, Knight DS, Coghlan JG, Petrie A, Whelan CJ, Venneri L, Martinez-Naharro A, Hawkins P, Fontana M, Gillmore JD.
    Eur J Heart Fail; 2024 Feb 18; 26(2):383-393. PubMed ID: 37953725
    [Abstract] [Full Text] [Related]

  • 12. A Descriptive Analysis of ATTR Amyloidosis in Spain from the Transthyretin Amyloidosis Outcomes Survey.
    González-Moreno J, Losada-López I, Cisneros-Barroso E, Garcia-Pavia P, González-Costello J, Muñoz-Beamud F, Campistol JM, Fernandez-Torron R, Chapman D, Amass L.
    Neurol Ther; 2021 Dec 18; 10(2):833-845. PubMed ID: 34331265
    [Abstract] [Full Text] [Related]

  • 13. Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS.
    Gentile L, Tournev I, Amass L, Chapman D, Mazzeo A, THAOS investigators.
    Cardiol Ther; 2021 Dec 18; 10(2):481-490. PubMed ID: 34148211
    [Abstract] [Full Text] [Related]

  • 14. Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review.
    Ungericht M, Wanschitz J, Kroiss AS, Röcken C, Schuetz T, Messner M, Zaruba MM, Loescher WN, Poelzl G.
    J Nucl Cardiol; 2023 Aug 18; 30(4):1420-1426. PubMed ID: 35581484
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Waddington-Cruz M, Wixner J, Amass L, Kiszko J, Chapman D, Ando Y, THAOS investigators.
    Neurol Ther; 2021 Dec 18; 10(2):753-766. PubMed ID: 34024024
    [Abstract] [Full Text] [Related]

  • 16. Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS).
    Damy T, Kristen AV, Suhr OB, Maurer MS, Planté-Bordeneuve V, Yu CR, Ong ML, Coelho T, Rapezzi C, THAOS Investigators.
    Eur Heart J; 2022 Feb 03; 43(5):391-400. PubMed ID: 30938420
    [Abstract] [Full Text] [Related]

  • 17. Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey.
    González-Moreno J, Dispenzieri A, Grogan M, Coelho T, Tournev I, Waddington-Cruz M, Wixner J, Diemberger I, Garcia-Pavia P, Chapman D, Gupta P, Glass O, Amass L, THAOS investigators.
    Cardiol Ther; 2024 Mar 03; 13(1):117-135. PubMed ID: 38117424
    [Abstract] [Full Text] [Related]

  • 18. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
    Porcari A, Razvi Y, Masi A, Patel R, Ioannou A, Rauf MU, Hutt DF, Rowczenio D, Gilbertson J, Martinez-Naharro A, Venneri L, Whelan C, Lachmann H, Wechalekar A, Quarta CC, Merlo M, Sinagra G, Hawkins PN, Fontana M, Gillmore JD.
    Eur J Heart Fail; 2023 Apr 03; 25(4):515-524. PubMed ID: 36644836
    [Abstract] [Full Text] [Related]

  • 19. Neuromuscular manifestations of wild type transthyretin amyloidosis: a review and single center's experience.
    Živković SA, Lacomis D, Soman P.
    Front Cardiovasc Med; 2024 Apr 03; 11():1345608. PubMed ID: 38410247
    [Abstract] [Full Text] [Related]

  • 20. Clinical and genetic profiles of patients with hereditary and wild-type transthyretin amyloidosis: the Transthyretin Cardiac Amyloidosis Registry in the state of São Paulo, Brazil (REACT-SP).
    Fernandes F, Luzuriaga GDCJ, da Fonseca GWP, Correia EB, Carvalho AAS, Macedo AVS, Coelho-Filho OR, Scheinberg P, Antunes MO, Schwartzmann PV, Mangini S, Marques W, Simões MV.
    Orphanet J Rare Dis; 2024 Jul 20; 19(1):273. PubMed ID: 39033298
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.